Measurable Residual Disease Testing by Next Generation Sequencing is More Accurate Compared with Multiparameter Flow Cytometry in Adults with B-cell Acute Lymphoblastic Leukemia
CANCER LETTERS(2024)
Key words
Acute lymphoblastic leukemia,Measurable residual disease,Next generation sequencing,Multi-parameter flow cytometry,Transplant
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined